All Stories

  1. Global Consensus Position Statement on the Use of Testosterone Therapy for Women

    Article • Climacteric, September 2019, Taylor & Francis

    johannes bitzer

  2. Contraception in cancer survivors – an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers

    Article • The European Journal of Contraception & Reproductive Health Care, May 2019, Taylor & Francis

    johannes bitzer

  3. Contraception in cancer survivors – an expert review Part I. Breast and gynaecological cancers

    Article • The European Journal of Contraception & Reproductive Health Care, April 2019, Taylor & Francis

    johannes bitzer

  4. Esmirtazapine treatment of postmenopausal vasomotor symptoms: two randomized controlled trials

    Article • Climacteric, February 2019, Taylor & Francis

    johannes bitzer, Sabine Braat

  5. James Trussell, BA, BPhil, PhD, 1949–2018

    Article • The European Journal of Contraception & Reproductive Health Care, January 2019, Taylor & Francis

    johannes bitzer

  6. James Trussell – an eminent scientist and advocate for women’s sexual and reproductive rights

    Article • The European Journal of Contraception & Reproductive Health Care, January 2019, Taylor & Francis

    johannes bitzer

  7. Overview of perimenopausal contraception

    Article • Climacteric, December 2018, Taylor & Francis

    johannes bitzer

  8. Managing the risks of mood symptoms with LNG-IUS: a clinical perspective

    Article • The European Journal of Contraception & Reproductive Health Care, September 2018, Taylor & Francis

    johannes bitzer, Claudio Soares

  9. Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study

    Article • The European Journal of Contraception & Reproductive Health Care, May 2018, Taylor & Francis

    johannes bitzer

  10. Answer to the letter of Marge Berer

    Article • The European Journal of Contraception & Reproductive Health Care, February 2018, Taylor & Francis

    johannes bitzer

  11. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

    Article • The European Journal of Contraception & Reproductive Health Care, July 2017, Taylor & Francis

    Giovanni Grandi, johannes bitzer, Shelley Raine

  12. Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?

    Article • The European Journal of Contraception & Reproductive Health Care, July 2017, Taylor & Francis

    Giovanni Grandi, johannes bitzer

  13. Forty to fifty-five-year-old women and iron deficiency: clinical considerations and quality of life

    Article • Gynecological Endocrinology, March 2017, Taylor & Francis

    johannes bitzer

  14. Hormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)

    Article • International Journal of Women s Health, May 2015, Dove Medical Press

    Dr Maria Jesusa B. Banal-Silao, johannes bitzer, Ulrike Wissinger

  15. Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol

    Article • Open Access Journal of Contraception, November 2013, Taylor & Francis

    johannes bitzer

  16. Women's attitudes towards heavy menstrual bleeding, and their impact on quality of life

    Article • Open Access Journal of Contraception, April 2013, Taylor & Francis

    johannes bitzer

  17. Women’s awareness and periconceptional use of folic acid: data from a large European survey

    Article • International Journal of Women s Health, April 2013, Taylor & Francis

    johannes bitzer

  18. Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest

    Article • International Journal of Women s Health, April 2011, Taylor & Francis

    johannes bitzer